Zions Bancorporation N.A. lifted its position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 21.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,211 shares of the technology company’s stock after acquiring an additional 2,486 shares during the period. Zions Bancorporation N.A.’s holdings in Novanta were worth $2,171,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also made changes to their positions in NOVT. Vanguard Group Inc. lifted its stake in Novanta by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 4,123,828 shares of the technology company’s stock worth $629,997,000 after purchasing an additional 62,585 shares during the last quarter. State Street Corp raised its holdings in shares of Novanta by 2.0% during the 3rd quarter. State Street Corp now owns 1,298,419 shares of the technology company’s stock worth $232,313,000 after buying an additional 24,929 shares in the last quarter. William Blair Investment Management LLC lifted its position in shares of Novanta by 1.2% during the 4th quarter. William Blair Investment Management LLC now owns 975,841 shares of the technology company’s stock worth $149,079,000 after buying an additional 11,361 shares during the last quarter. Geneva Capital Management LLC boosted its stake in Novanta by 9.3% in the fourth quarter. Geneva Capital Management LLC now owns 852,638 shares of the technology company’s stock valued at $130,257,000 after buying an additional 72,592 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Novanta by 8.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 793,359 shares of the technology company’s stock valued at $119,757,000 after acquiring an additional 58,631 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Stock Performance
Shares of Novanta stock opened at $136.82 on Wednesday. The company’s 50 day moving average price is $143.90 and its two-hundred day moving average price is $159.28. The firm has a market capitalization of $4.92 billion, a P/E ratio of 81.93 and a beta of 1.34. Novanta Inc. has a fifty-two week low of $131.03 and a fifty-two week high of $187.12. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81.
Wall Street Analyst Weigh In
Separately, Robert W. Baird dropped their target price on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a report on Monday, March 3rd.
Read Our Latest Stock Analysis on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Recommended Stories
- Five stocks we like better than Novanta
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- 3 Warren Buffett Stocks to Buy Now
- NVIDIA Insiders Sell: This Is What It Means for the MarketÂ
- Trading Halts Explained
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.